Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Antibiotic-associated diarrhea due to Clostridium difficile (CDAD) is thought to reflect colonization of a disrupted microbial community by the pathogen. We profiled the fecal microbiota of patients with CDAD (both initial and recurrent episodes) by culture-independent phylogenetic analysis of 16S rRNA-encoding gene sequences. Compared with those from control subjects and patients with an initial episode, the fecal communities in patients with recurrent CDAD were highly variable in bacterial composition and were characterized by markedly decreased diversity. Preservation and restoration of the microbial diversity could represent novel strategies for prevention and treatment of recurrent CDAD, which is often recalcitrant to existing therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, a small, open label pilot study comparing upper and lower GI routes of administration did not show any differences44”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [44]
In the citing paper
“The human gut microbiota can restrict the growth of pathogens to prevent them from colonizing the intestine (‘colonization resistance’).”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [28]
In the citing paper
“Gut microbiota with high diversity have higher colonization resistance than gut microbiota with low diversity as a result of antibiotic treatment [28].”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [28]
Citations
Cites
Measuring biological diversity
(2004) · Choice Reviews Online · doi:10.5860/choice.42-1547 · Cited by 6,621
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 3×
“exist in a complex symbiosis with their host [5].”
BackgroundInfluentialSchloss, P. D., & Handelsman, J. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.3.1501-1506.2005 · Cited by 2,501 · cited 1×
“The distance matrix was fed into DOTUR [8] to group the sequences into operational taxonomic units (OTUs), calculate ecological diversity measures (including the Shannon index [9]), and generate rarefaction curves by use of an OTU definition of 97% sequence similarity.”
MethodAntibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197 · cited 1×
“Diarrhea is a common side effect of the administration of antibiotics, with Clostridium difficile being responsible for most of the severe cases of antibiotic-associated diarrhea (AAD), including the development of pseudomembranous colitis [1].”
BackgroundMcFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872 · cited 1×
“difficile antibiotics or the administration of probiotic organisms— have been tried for treatment of RCD [12, 13] [14].”
BackgroundKyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804 · cited 1×
“difficile toxin [11].”
Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease
McFarland, L. V., Elmer, G. W., & Surawicz, C. M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05839.x · Cited by 724 · cited 1×
“difficile antibiotics or the administration of probiotic organisms— have been tried for treatment of RCD [12, 13] [14].”
BackgroundAas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518 · cited 1×
“individuals to patients with RCD [4, 15]—is to alter the patient’s microbiome and to restore colonization resistance.”
BackgroundBACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS
Tvede, M., & Rask-Madsen, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92749-9 · Cited by 491
Vollaard, E. J., & Clasener, H. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.409 · Cited by 478 · cited 1×
“microbiota is that of “colonization resistance” [10].”
Cited by
Items 101–200 of 999
Epidemiology of Clostridium difficile Infection
DePestel, D. D., & Aronoff, D. M. (2013) · Journal of Pharmacy Practice · doi:10.1177/0897190013499521 · Cited by 244
“’’(72) Antibacterials can disrupt the competitive balance or homeostasis in the gut microbiota and promote the overgrowth of C difficile, serving as a major step in the development of CDI.(72) Recurrent CDI after treatment with vancomycin or metronidazole, to some extent, is thought to be related to the ability of the…”
BackgroundBacterial Communities of the Coronal Sulcus and Distal Urethra of Adolescent Males
Nelson, D. E., Dong, Q., Van Der Pol, B., Toh, E., Fan, B., Katz, B. P., Mi, D., Rong, R., Weinstock, G. M., Sodergren, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036298 · Cited by 242
Britton, R. A., & Young, V. B. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.04.001 · Cited by 240
“Support for reduced microbiome diversity in recurrent CDI was found in a small sample of patients recovering from CDI infection [29].”
BackgroundSelf-citationMorphine induces changes in the gut microbiome and metabolome in a morphine dependence model
Wang, F., Meng, J., Zhang, L., Johnson, T., Chen, C., & Roy, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-21915-8 · Cited by 238
Bien, J., Palagani, V., & Bozko, P. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12454590 · Cited by 238
“difficile to colonize the intestine [Wilson, 1993; Chang et al. 2008; De La Cochetière et al. 2008].”
BackgroundInfluentialLi, E., Hamm, C. M., Gulati, A. S., Sartor, R. B., Chen, H., Wu, X., Zhang, T., Rohlf, F. J., Zhu, W., Gu, C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0026284 · Cited by 236
Rea, M. C., O'Sullivan, O., Shanahan, F., O'Toole, P. W., Stanton, C., Ross, R. P., & Hill, C. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05176-11 · Cited by 222
Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention
Song, J. H., & Kim, Y. S. (2019) · Gut and Liver · doi:10.5009/gnl18071 · Cited by 219
Skin microbiota: Microbial community structure and its potential association with health and disease
Rosenthal, M., Goldberg, D., Aiello, A., Larson, E., & Foxman, B. (2011) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2011.03.022 · Cited by 222
“By contrast, among 3 patients with recurrent antibiotic-associated diarrhea due to Clostridium difficile, bacterial diversity was lower in the fecal microbiome compared to that found among 7 controls (Chang et al, 2008).”
ResultBiological aging and the human gut microbiota
Maffei, V. J., Kim, S., Blanchard, E., Luo, M., Jazwinski, S. M., Taylor, C. M., & Welsh, D. A. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx042 · Cited by 219
Fecal bacteriotherapy for recurrent Clostridium difficile infection
Bakken, J. S. (2009) · Anaerobe · doi:10.1016/j.anaerobe.2009.09.007 · Cited by 218
De Leon, L. M., Watson, J. B., & Kelly, C. R. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.045 · Cited by 215
Narula, N., Kassam, Z., Yuan, Y., Colombel, J.-F., Ponsioen, C., Reinisch, W., & Moayyedi, P. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001228 · Cited by 211
Vedantam, G., Clark, A., Chu, M., McQuade, R., Mallozzi, M., & Viswanathan, V. K. (2012) · Gut Microbes · doi:10.4161/gmic.19399 · Cited by 209
Kurokawa, S., Kishimoto, T., Mizuno, S., Masaoka, T., Naganuma, M., Liang, K.-C., Kitazawa, M., Nakashima, M., Shindo, C., Suda, W., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.038 · Cited by 205
The gut microbiome is altered in a letrozole-induced mouse model of polycystic ovary syndrome
Kelley, S. T., Skarra, D. V., Rivera, A. J., & Thackray, V. G. (2016) · PLOS ONE · doi:10.1371/journal.pone.0146509 · Cited by 205
Development of the Pediatric Gut Microbiome: Impact on Health and Disease
Ihekweazu, F. D., & Versalovic, J. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.08.005 · Cited by 198
“These compositional changes are even more pronounced in patients with recurrent CDI who have been exposed to multiple courses of antbiotics.(70) Recurrent CDI leads to increased abundance of Proteobacteria, with decreased abundances of Bacteroidetes and Firmicutes compared to healthy controls.”
Therapeutic modulation of intestinal dysbiosis
Walker, A. W., & Lawley, T. D. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.09.008 · Cited by 200
Seekatz, A. M., Theriot, C. M., Rao, K., Chang, Y.-M., Freeman, A. E., Kao, J. Y., & Young, V. B. (2018) · Anaerobe · doi:10.1016/j.anaerobe.2018.04.001 · Cited by 198
“Similarly, it is hypothesized that attenuated recovery of the microbiota following antibiotic use contributes to the development of recurrence (4, 5).”
BackgroundSelf-citationLife history and eco‐evolutionary dynamics in light of the gut microbiota
Macke, E., Tasiemski, A., Massol, F., Callens, M., & Decaestecker, E. (2017) · Oikos · doi:10.1111/oik.03900 · Cited by 196
The influence of proton pump inhibitors and other commonly used medication on the gut microbiota
Imhann, F., Vich Vila, A., Bonder, M. J., Lopez Manosalva, A. G., Koonen, D. P. Y., Fu, J., Wijmenga, C., Zhernakova, A., & Weersma, R. K. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1284732 · Cited by 192
Shahinas, D., Silverman, M., Sittler, T., Chiu, C., Kim, P., Allen-Vercoe, E., Weese, S., Wong, A., Low, D. E., & Pillai, D. R. (2012) · mBio · doi:10.1128/mbio.00338-12 · Cited by 191
“Nevertheless, we observe the same paucity of Bacteroidetes and overexpansion of Proteobacteria seen by other studies of the CDI disease state in the absence of prior therapy with vancomycin (18, 43).”
BackgroundResultThe role of the intestinal microbiota in enteric infection
Sekirov, I., & Finlay, B. B. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.172742 · Cited by 189
“…frequent complication of antibiotic therapy (Owens et al. 2008), were characterized by a decreased diversity in the fecal microbial community (Chang et al. 2008), while the main bacterial components of the fecal flora were found to have some predictive value for the future development of C.…”
BackgroundModulation of immune homeostasis by commensal bacteria
Ivanov, I. I., & Littman, D. R. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.12.003 · Cited by 188
“In animal models, pathogenic changes in the composition of microbiota have been found upon breakdown of host immune homeostasis mechanisms [34], and in humans there can be similar dysbiosis following treatment with antibiotics, particularly in immunocompromised individuals [35].”
BackgroundFrom Stool Transplants to Next-Generation Microbiota Therapeutics
Petrof, E. O., & Khoruts, A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.004 · Cited by 186
Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options
Lo Vecchio, A., & Zacur, G. M. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32834bc9a9 · Cited by 183
Success of Self-Administered Home Fecal Transplantation for Chronic Clostridium difficile Infection
Silverman, M. S., Davis, I., & Pillai, D. R. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.01.007 · Cited by 181
The intestinal microbiome and health
Tuddenham, S., & Sears, C. L. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000196 · Cited by 180
Human Microbiota Characterization in the Course of Renal Transplantation
Fricke, W. F., Maddox, C., Song, Y., & Bromberg, J. S. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12588 · Cited by 176
Changes in the Intestinal Microbiota of Wild Atlantic cod Gadus morhua L. Upon Captive Rearing
Dhanasiri, A. K. S., Brunvold, L., Brinchmann, M. F., Korsnes, K., Bergh, Ø., & Kiron, V. (2011) · Microbial Ecology · doi:10.1007/s00248-010-9673-y · Cited by 176
“On the other hand, bands 3 [51] and 7 [8] were closely related to a community in human feces, whereas band 6 [21] was related to that from spotted hyena feces.”
BackgroundA mountable toilet system for personalized health monitoring via the analysis of excreta
Park, S.-M., Won, D. D., Lee, B. J., Escobedo, D., Esteva, A., Aalipour, A., Ge, T. J., Kim, J. H., Suh, S., Choi, E. H., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0534-9 · Cited by 175
Fuentes, S., van Nood, E., Tims, S., Heikamp-de Jong, I., ter Braak, C. J. F., Keller, J. J., Zoetendal, E. G., & de Vos, W. M. (2014) · The ISME Journal · doi:10.1038/ismej.2014.13 · Cited by 175
“The main components of the observed changes in composition were Bacilli (mostly small intestinal bacteria) and Proteobacteria (including vancomycin-resistant and potentially pathogenic bacteria).”
BackgroundInfluentialProbiotic Approach to Pathogen Control in Premise Plumbing Systems? A Review
Wang, H., Edwards, M. A., Falkinham, J. O., & Pruden, A. (2013) · Environmental Science & Technology · doi:10.1021/es402455r · Cited by 175
Investigating the biological and clinical significance of human dysbioses
Frank, D. N., Zhu, W., Sartor, R. B., & Li, E. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.06.005 · Cited by 175
Clostridium difficile – From Colonization to Infection
Schäffler, H., & Breitrück, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00646 · Cited by 174
“Furthermore, Ruminococcacea, Lachnospiraceae, Bacteriodaceae, Clostrida cluster IV and XIVa are decreased while an increased abundance of Enterococacea could be observed (Chang et al., 2008; Antharam et al., 2013; Hamilton et al., 2013).”
BackgroundRegulation, risk and safety of Faecal Microbiota Transplant
Merrick, B., Allen, L., Masirah M Zain, N., Forbes, B., Shawcross, D. L., & Goldenberg, S. D. (2020) · Infection Prevention in Practice · doi:10.1016/j.infpip.2020.100069 · Cited by 171
Brandt, L. J. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.450 · Cited by 171
Microbial diversity in individuals and their household contacts following typical antibiotic courses
Abeles, S. R., Jones, M. B., Santiago-Rodriguez, T. M., Ly, M., Klitgord, N., Yooseph, S., Nelson, K. E., & Pride, D. T. (2016) · Microbiome · doi:10.1186/s40168-016-0187-9 · Cited by 169
“This focus in some cases is related to the commonly known effects of these drugs on human gut microbes, with ciprofloxacin having broad activity against Proteobacteria that inhabit the gut, and clindamycin known to alter gut microbiota in a manner that is closely associated with colonization and subsequent disease cau…”
A comparison of the gut microbiome between long‐term users and non‐users of proton pump inhibitors
Clooney, A. G., Bernstein, C. N., Leslie, W. D., Vagianos, K., Sargent, M., Laserna‐Mendieta, E. J., Claesson, M. J., & Targownik, L. E. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13568 · Cited by 166
“Non–PPI (29) PPI (32) Non–PPI (29) PPI (32) Non–PPI (29) PPI (32) P-Value: 0.”
InfluentialClinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity
Dingle, K. E., Griffiths, D., Didelot, X., Evans, J., Vaughan, A., Kachrimanidou, M., Stoesser, N., Jolley, K. A., Golubchik, T., Harding, R. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019993 · Cited by 165
Seto, C. T., Jeraldo, P., Orenstein, R., Chia, N., & DiBaise, J. K. (2014) · Microbiome · doi:10.1186/2049-2618-2-42 · Cited by 163
“The loss of colonic microbial diversity is a characteristic feature of CDI [23,24].”
BackgroundAntibiotic administration alters the community structure of the gastrointestinal microbiota
Robinson, C. J., & Young, V. B. (2010) · Gut Microbes · doi:10.4161/gmic.1.4.12614 · Cited by 161
Self-citationLappan, R., Imbrogno, K., Sikazwe, C., Anderson, D., Mok, D., Coates, H., Vijayasekaran, S., Bumbak, P., Blyth, C. C., Jamieson, S. E., et al. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1154-3 · Cited by 162
“This is in contrast to studies of the gut microbiome (a high-diversity environment [88]), where greater diversity has been associated with a healthy state, and a decrease in diversity is characteristic of disease [89, 90].”
ResultTherapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis
Haak, B. W., Prescott, H. C., & Wiersinga, W. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02042 · Cited by 159
“In addition, it has been shown that a state of disturbance of the intestinal microbiota, otherwise known as dysbiosis, plays an important role in increasing susceptibility to infectious diseases (17, 18).”
BackgroundMcGovern, B. H., Ford, C. B., Henn, M. R., Pardi, D. S., Khanna, S., Hohmann, E. L., O’Brien, E. J., Desjardins, C. A., Bernardo, P., Wortman, J. R., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa387 · Cited by 159
“difficile vegetative bacteria, they have no impact on dormant spores, which germinate when dysbiosis persists [4].”
BackgroundToward a Deeper Understanding of Gut Microbiome in Depression: The Promise of Clinical Applicability
Liu, L., Wang, H., Zhang, H., Chen, X., Zhang, Y., Wu, J., Zhao, L., Wang, D., Pu, J., Ji, P., et al. (2022) · Advanced Science · doi:10.1002/advs.202203707 · Cited by 158
Ling, Z., Liu, X., Jia, X., Cheng, Y., Luo, Y., Yuan, L., Wang, Y., Zhao, C., Guo, S., Li, L., et al. (2014) · Scientific Reports · doi:10.1038/srep07485 · Cited by 158
Jacobs, D., Gaudier, E., Duynhoven, J., & Vaughan, E. (2009) · Current Drug Metabolism · doi:10.2174/138920009787048383 · Cited by 157
“The fecal microbial communities in patients with recurrent antibiotic-associated diarrhoea due to Clostridium difficile were highly variable in bacterial composition and were also characterized by markedly decreased diversity [36].”
BackgroundLung Microbiome for Clinicians. New Discoveries about Bugs in Healthy and Diseased Lungs
Segal, L. N., Rom, W. N., & Weiden, M. D. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201310-339fr · Cited by 171
Auchtung, J. M., Robinson, C. D., & Britton, R. A. (2015) · Microbiome · doi:10.1186/s40168-015-0106-5 · Cited by 155
“, [9–11]), the availability of less complex models of the microbiota (i.”
BackgroundDirect sequencing of the human microbiome readily reveals community differences
Kuczynski, J., Costello, E. K., Nemergut, D. R., Zaneveld, J., Lauber, C. L., Knights, D., Koren, O., Fierer, N., Kelley, S. T., Ley, R. E., et al. (2010) · Genome Biology · doi:10.1186/gb-2010-11-5-210 · Cited by 160
Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology
Khoruts, A., Staley, C., & Sadowsky, M. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0350-4 · Cited by 155
DuPont, H. L. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0904162 · Cited by 155
Lozupone, C., Rhodes, M. E., Neff, C. P., Fontenot, A. P., Campbell, T., & Palmer, B. E. (2014) · Gut Microbes · doi:10.4161/gmic.32132 · Cited by 188
“Decreased α diversity has been described in many different inflammatory and/or disturbed states of the gut, including diarrhea.(19) Taken together, this suggests that the combined effects of ART and of HIV infection itself, whose effects are not entirely mitigated by ART, may induce a “double hit” to the microbiota.”
BackgroundThe Tasmanian devil microbiome—implications for conservation and management
Cheng, Y., Fox, S., Pemberton, D., Hogg, C. J., Papenfuss, A. T., & Belov, K. (2015) · Microbiome · doi:10.1186/s40168-015-0143-0 · Cited by 163
Characterization of the human gut microbiome during travelers' diarrhea
Youmans, B. P., Ajami, N. J., Jiang, Z., Campbell, F., Wadsworth, W. D., Petrosino, J. F., DuPont, H. L., & Highlander, S. K. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1019693 · Cited by 168
“In all cases, the healthy controls contained a high Bacteroidetes:Firmicutes ratio and the diseased groups contained lower Bacteroidetes:Firmicutes ratios.(11-14,16) Generally, increased bacterial diversity is associated with a healthy gut, and the above studies also associated decreases in a-diversity to obesity, IBS…”
BackgroundManges, A. R., Labbe, A., Loo, V. G., Atherton, J. K., Behr, M. A., Masson, L., Tellis, P. A., & Brousseau, R. (2010) · The Journal of Infectious Diseases · doi:10.1086/657319 · Cited by 149
“Our results did not confirm reports that low microbial diversity may be related to CDAD development [41], nor did we find more homogeneous microbiota among patients with CDAD.”
ResultBuonomo, E. L., Cowardin, C. A., Wilson, M. G., Saleh, M. M., Pramoonjago, P., & Petri, W. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.007 · Cited by 155
“Lastly, CDI has been shown to sustain microbial dysbiosis in the intestine conferred by initial antibiotic treatment (Antharam et al., 2013; Chang et al., 2008; Engevik et al., 2015).”
BackgroundCross-feeding modulates antibiotic tolerance in bacterial communities
Adamowicz, E. M., Flynn, J., Hunter, R. C., & Harcombe, W. R. (2018) · The ISME Journal · doi:10.1038/s41396-018-0212-z · Cited by 147
Chen, S., Wang, J., Dandan, P., Li, G., Chen, J., & Gu, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-32886-1 · Cited by 188
Breakthroughs in the treatment and prevention of Clostridium difficile infection
Kociolek, L. K., & Gerding, D. N. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.220 · Cited by 168
Seekatz, A. M., Theriot, C. M., Molloy, C. T., Wozniak, K. L., Bergin, I. L., & Young, V. B. (2015) · Infection and Immunity · doi:10.1128/iai.00459-15 · Cited by 143
“Previous studies have suggested that patients who develop recurrence have a less diverse community than patients who have stable recovery (12).”
BackgroundSelf-citationMetataxonomic and Metagenomic Approaches vs. Culture-Based Techniques for Clinical Pathology
Hilton, S. K., Castro‐Nallar, E., Pérez‐Losada, M., Toma, I., McCaffrey, T. A., Hoffman, E. P., Siegel, M., Simon, G. L., Johnson, W. E., & Crandall, K. A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00484 · Cited by 167
Update of treatment algorithms for Clostridium difficile infection
Ooijevaar, R. E., van Beurden, Y. H., Terveer, E. M., Goorhuis, A., Bauer, M. P., Keller, J. J., Mulder, C. J. J., & Kuijper, E. J. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.12.022 · Cited by 152
Dubberke, E. R., Lee, C. H., Orenstein, R., Khanna, S., Hecht, G., & Gerding, D. N. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy259 · Cited by 140
The intestinal microbiota and susceptibility to infection in immunocompromised patients
Taur, Y., & Pamer, E. G. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283630dd3 · Cited by 139
“difficile infection had relatively reduced microbial diversity in their feces [52].”
BackgroundRousseau, C., Levenez, F., Fouqueray, C., Doré, J., Collignon, A., & Lepage, P. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01507-10 · Cited by 138
“showed a decreased fecal microbiota diversity in adults with recurrent CDI (4).”
BackgroundPassmore, I. J., Letertre, M. P. M., Preston, M. D., Bianconi, I., Harrison, M. A., Nasher, F., Kaur, H., Hong, H. A., Baines, S. D., Cutting, S. M., et al. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007191 · Cited by 138
Dysbiotic bacteria translocate in progressive SIV infection
Klase, Z. A., Ortiz, A. M., Deléage, C., Mudd, J. C., Quiñones, M., Schwartzman, E., Klatt, N. R., Canary, L., Estes, J. D., & Brenchley, J. M. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.128 · Cited by 143
Rubin, T. A., Gessert, C. E., Aas, J., & Bakken, J. (2012) · Anaerobe · doi:10.1016/j.anaerobe.2012.11.004 · Cited by 142
“difficile infection have been found to have decreased diversity in their stool microbiome [25,26].”
BackgroundZhang, L., Dong, D., Jiang, C., Li, Z., Wang, X., & Peng, Y. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.03.008 · Cited by 158
Gut microbiota trajectory in early life may predict development of celiac disease
Olivares, M., Walker, A. W., Capilla, A., Benítez‐Páez, A., Palau, F., Parkhill, J., Castillejo, G., & Sanz, Y. (2018) · Microbiome · doi:10.1186/s40168-018-0415-6 · Cited by 152
Is It Time for a Metagenomic Basis of Therapeutics?
Haiser, H. J., & Turnbaugh, P. J. (2012) · Science · doi:10.1126/science.1224396 · Cited by 133
Wang, Z.-K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14805 · Cited by 133
Association Study of Gut Flora in Coronary Heart Disease through High-Throughput Sequencing
Cui, L., Zhao, T., Hu, H., Zhang, W., & Hua, X. (2017) · BioMed Research International · doi:10.1155/2017/3796359 · Cited by 149
Inference of Network Dynamics and Metabolic Interactions in the Gut Microbiome
Steinway, S. N., Biggs, M. B., Loughran, T. P., Papin, J. A., & Albert, R. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004338 · Cited by 130
“difficile will subsequently fill [7–10].”
Defining Dysbiosis in Patients with Urolithiasis
Zampini, A. M., Nguyen, A. H., Rose, E., Monga, M., & Miller, A. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-41977-6 · Cited by 144
Plasmid-mediated metronidazole resistance in Clostridioides difficile
Boekhoud, I. M., Hornung, B., Sevilla, E., Harmanus, C., Sanders, I. M. J. G., Terveer, E. M., Bolea, R., Corver, J., Kuijper, E. J., & Smits, W. K. (2020) · Nature Communications · doi:10.1038/s41467-020-14382-1 · Cited by 143
Alterations in the Colonic Microbiota in Response to Osmotic Diarrhea
Gorkiewicz, G., Thallinger, G. G., Trajanoski, S., Lackner, S., Stocker, G., Hinterleitner, T., Gülly, C., & Högenauer, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055817 · Cited by 130
Gut Microbiome Toxicity: Connecting the Environment and Gut Microbiome-Associated Diseases
Tu, P., Chi, L., Bodnar, W. M., Zhang, Z., Gao, B., Bian, X., Stewart, J. R., Fry, R. C., & Lü, K. (2020) · Toxics · doi:10.3390/toxics8010019 · Cited by 146
The immunological functions of the Appendix: An example of redundancy?
Girard-Madoux, M. J. H., de Agüero, M. G., Ganal-Vonarburg, S. C., Mooser, C., Belz, G. T., Macpherson, A. J., & Vivier, É. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.02.005 · Cited by 155
Pettit, L. J., Browne, H. P., Yu, L., Smits, W. K., Fagan, R. P., Barquist, L., Martin, M. J., Goulding, D., Duncan, S. H., Flint, H. J., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-160 · Cited by 127
“difficile can produce a number of potent virulence-associated factors that contribute to intestinal colonization and disease [8], and facilitate the establishment of a pathological imbalance within the resident microbiota [9].”
BackgroundDavidovics, Z. H., Michail, S., Nicholson, M. R., Kociolek, L. K., Pai, N., Hansen, R., Schwerd, T., Maspons, A., Shamir, R., Szajewska, H., et al. (2019) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002205 · Cited by 126
“Decreased microbial diversity is associated with a high risk of CDI recurrence (91,92).”
BackgroundMicrobial Metabolism Modulates Antibiotic Susceptibility within the Murine Gut Microbiome
Cabral, D. J., Penumutchu, S., Reinhart, E. M., Zhang, C., Korry, B. J., Wurster, J. I., Nilson, R., Guang, A., Sano, W. H., Rowan-Nash, A. D., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.020 · Cited by 142
“Most notably, antibiotic treatment increases the risk of Clostridioides-difficile-induced colitis, a major nosocomial infection estimated to have resulted in 29,000 deaths in 2011 alone (Chang et al., 2008; Lessa et al., 2015; Theriot et al., 2016).”
BackgroundGut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?
Quigley, E. M. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.29 · Cited by 125
Khanna, S., Montassier, E., Schmidt, B., Patel, R., Knights, D., Pardi, D. S., & Kashyap, P. C. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13750 · Cited by 124
Microbial ecosystems therapeutics: a new paradigm in medicine?
Petrof, E. O., Claud, E. C., Gloor, G. B., & Allen-Vercoe, E. (2013) · Beneficial Microbes · doi:10.3920/bm2012.0039 · Cited by 123
“This is well illustrated by one study that used 16S rRNA analysis to sequence and analyse bacterial DNA from stool samples of 10 patients: 4 patients with CDI, 3 patients with recurrent CDI and 3 healthy controls (Chang et al., 2008).”
BackgroundMethodInfluentialVincent, C., Stephens, D. A., Loo, V. G., Edens, T. J., Behr, M. A., Dewar, K., & Manges, A. R. (2013) · Microbiome · doi:10.1186/2049-2618-1-18 · Cited by 123
“Other authors have assessed intestinal microbiota alterations in patients with an initial or recurrent episode of CDI [25-27,37].”
BackgroundGut microbiome health and dysbiosis: A clinical primer
Bidell, M. R., Hobbs, A. L. V., & Lodise, T. P. (2022) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2731 · Cited by 163
The ecosystem services of animal microbiomes
McKenney, E. A., Koelle, K., Dunn, R. R., & Yoder, A. D. (2018) · Molecular Ecology · doi:10.1111/mec.14532 · Cited by 131
“While these opportunists and potential pathogens also proliferate in gut environments where diarrhoea or antibiotic treatment disrupt the stable climax community (Figure 2B) (Chang et al., 2008; McKenney, Greene et al., 2017; McKenney, O’Connell et al., 2017), they too are out-competed as subjects recover and resume c…”
BackgroundRussell, G., Kaplan, J., Ferraro, M., & Michelow, I. C. (2010) · PEDIATRICS · doi:10.1542/peds.2009-3363 · Cited by 120
Using high throughput sequencing to explore the biodiversity in oral bacterial communities
Diaz, P. I., Dupuy, A. K., Abusleme, L., Reese, B., Obergfell, C., Choquette, L., Dongari‐Bagtzoglou, A., Peterson, D. E., Terzi, E., & Strausbaugh, L. D. (2012) · Molecular Oral Microbiology · doi:10.1111/j.2041-1014.2012.00642.x · Cited by 118
“Indeed, disturbance of these communities and changes in their composition have been associated with the development of a variety of diseases (Eckburg & Relman, 2007; Chang et al., 2008; Turnbaugh & Gordon, 2009; Ravel et al., 2011).”
BackgroundThe human jejunum has an endogenous microbiota that differs from those in the oral cavity and colon
Sundin, O. H., Mendoza-Ladd, A., Zeng, M., Diaz-Arévalo, D., Morales, E., Fagan, B. M., Ordoñez, J., Velez, P., Antony, N., & McCallum, R. W. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1059-6 · Cited by 120
“Pathogenic bacterial infections are often characterized by a large and broad-based decrease in species diversity, in part due to the dominance of a small number of species [8, 9, 28, 29].”
Elevated Seawater Temperatures Decrease Microbial Diversity in the Gut of Mytilus coruscus
Li, Y., Yang, N., Liang, X., Yoshida, A., Osatomi, K., Power, D. M., Batista, F. M., & Yang, J.-L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00839 · Cited by 127
“This is indirectly supported by studies that reveal impaired health status is strongly associated with low microbial diversity in many organisms (Garnier et al., 2007; Chang et al., 2008; Green and Barnes, 2010).”
BackgroundAguilera, M., Vergara, P., & Martínez, V. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12154 · Cited by 119
Hierarchical social networks shape gut microbial composition in wild Verreaux's sifaka
Perofsky, A. C., Lewis, R. J., Abondano, L. A., Di Fiore, A., & Meyers, L. A. (2017) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2017.2274 · Cited by 117
Li, Q., Wang, C., Tang, C., He, Q., Zhao, X., Li, N., & Li, J. (2015) · Critical Care · doi:10.1186/s13054-015-0738-7 · Cited by 118
“gut microbiota [6].”
Is primary prevention of Clostridium difficile infection possible with specific probiotics?
Johnson, S., Maziade, P.-J., McFarland, L. V., Trick, W., Donskey, C., Currie, B., Low, D. E., & Goldstein, E. J. C. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.06.005 · Cited by 117
Seekatz, A. M., Rao, K. K., Santhosh, K., & Young, V. B. (2016) · Genome Medicine · doi:10.1186/s13073-016-0298-8 · Cited by 129
“A previous small study demonstrated that patients with recurrent disease have a less diverse community than patients with nonrecurrent CDI [38].”
BackgroundSelf-citationHan, G., Kim, E. B., Lee, J., Lee, J.-Y., Jin, G.-D., Park, J., Huh, C., Kwon, I. K., Kil, D. Y., Choi, Y.-J., et al. (2016) · SpringerPlus · doi:10.1186/s40064-016-2604-8 · Cited by 145
Metadata
- Authors
- Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B.
- Affiliations
- Michigan State University (US)
- Corresponding author
- Young, Vincent B.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-02
- Volume
- 197
- Issue
- 3
- Pages
- 435-438
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2139607253
- Cited by
- 1,010
- References
- 15
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 36 · 2023: 54 · 2022: 42 · 2021: 57 · 2020: 69 · 2019: 59 · 2018: 107 · 2017: 78 · 2016: 77 · 2015: 88 · 2014: 87 · 2013: 78 · 2012: 53
- FWCI
- 17.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- Clostridium difficile, fecal microbiota, microbial diversity, antibiotic-associated diarrhea, 16S rRNA gene sequencing, bacterial community composition, dysbiosis, microbiota restoration
- MeSH terms
- Anti-Bacterial Agents, Diarrhea, Drug Administration Schedule, Enterocolitis, Pseudomembranous, Feces, Female, Humans, Male, Phylogeny, Recurrence, Reference Values, Genetic Variation, Clostridioides difficile
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.